Authors:
Whiteman, MK
Cui, YD
Flaws, JA
Langenberg, P
Bush, TL
Citation: Mk. Whiteman et al., Media coverage of women's health issues: Is there a bias in the reporting of an association between hormone replacement therapy and breast cancer?, J WOMEN H G, 10(6), 2001, pp. 571-577
Authors:
Lewis, BC
Hudgins, S
Lewis, A
Schorr, K
Sommer, R
Peterson, RE
Flaws, JA
Furth, PA
Citation: Bc. Lewis et al., In utero and lactational treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin impairs mammary gland differentiation but does not block the response to exogenous estrogen in the postpubertal female rat (vol 62, pg 46, 2001), TOXICOL SCI, 64(1), 2001, pp. CP2-CP2
Authors:
Lewis, BC
Hudgins, S
Lewis, A
Schorr, K
Sommer, R
Peterson, RE
Flaws, JA
Furth, PA
Citation: Bc. Lewis et al., In utero and lactational treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin impairs mammary gland differentiation but does not block the response to exogenous estrogen in the postpubertal female rat, TOXICOL SCI, 62(1), 2001, pp. 46-53
Authors:
Cui, YD
Blumenthal, RS
Flaws, JA
Whiteman, MK
Langenberg, P
Bachorik, PS
Bush, TL
Citation: Yd. Cui et al., Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality, ARCH IN MED, 161(11), 2001, pp. 1413-1419
Authors:
Davis, MA
Flaws, JA
Young, M
Collins, K
Colburn, NH
Citation: Ma. Davis et al., Effect of ceramide on intracellular glutathione determines apoptotic or necrotic cell death of JB6 tumor cells, TOXICOL SCI, 53(1), 2000, pp. 48-55
Authors:
Rucker, EB
Dierisseau, P
Wagner, KU
Garrett, L
Wynshaw-Boris, A
Flaws, JA
Hennighausen, L
Citation: Eb. Rucker et al., Bcl-x and bax regulate mouse primordial germ cell survival and apoptosis during embryogenesis, MOL ENDOCR, 14(7), 2000, pp. 1038-1052
Citation: Ek. Silbergeld et Ja. Flaws, Chemicals and menopause: Effects on age at menopause and on health status in the postmenopausal period, J WOMENS HE, 8(2), 1999, pp. 227-234
Authors:
Whiteman, MK
Cui, YD
Flaws, JA
Espeland, M
Bush, TL
Citation: Mk. Whiteman et al., Low fibrinogen level: A predisposing factor for venous thromboembolic events with hormone replacement therapy, AM J HEMAT, 61(4), 1999, pp. 271-273